Aaberge Ingeborg S
Department Director, Department of Bacteriology & Immunology, Division of Infectious Disease Control, Norwegian Institute of Public Health, PO Box 4404, Nydalen, NO-0403 Oslo, Norway.
Expert Rev Vaccines. 2009 Feb;8(2):159-65. doi: 10.1586/14760584.8.2.159.
Seven-valent pneumococcal conjugate vaccine (PCV7) was introduced into the Norwegian childhood vaccination program in July 2006 in a 2+1 dose (three-dose) schedule. Vaccine coverage quickly reached high levels and the incidence rate of invasive pneumococcal disease in children under 2 years of age declined rapidly. The vaccine program's effectiveness was estimated to be 74%.
七价肺炎球菌结合疫苗（PCV7）于2006年7月被纳入挪威儿童疫苗接种计划，采用2+1剂量（三剂）接种程序。疫苗接种覆盖率迅速达到高水平，2岁以下儿童侵袭性肺炎球菌疾病的发病率迅速下降。据估计，该疫苗计划的有效性为74%。
